Chou Associates Management
13F Holdings and Portfolio Analysis
Francis Chou 2017 Q2 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Chou Associates Management Overview
Chou Associates Management held 27 stocks in 2017 Q2, with total market value around $0.32B.
Chou Associates Management's top five holdings in 2017 Q2: VALEANT PHARMACEUTICALS INTL 16.38%, BERKSHIRE HATHAWAY INC CL A(BRK.A) 11.84%, JPMORGAN CHASE & CO 9.76%, WELLS FARGO & CO NEW 6.87%, RESOLUTE FST PRODS INC 6.77%.
- Portfolio Value
- $0.32B
- Current Holdings
- 27 stocks
- New / Increased
- 0 / 2
- Reduced / Exited
- 2 / 0
Current Holdings
| 1 | VALEANT PHARMACEUTICALS INTLCUSIP 91911K102 | 0.05 | 16.38% | 3.05 +29.74% | $17.36 | - | $16.16 | +0.70 | 1.50 | +$0.00B+7.45% | Increased |
| 2 | BERKSHIRE HATHAWAY INC CL ABRK.A | 0.04 | 11.84% | 0.00 - | $255653.33 | $705400.23 +175.92% | $168600.00 | 0.00 | 4.25 | +$0.08B+318.39% | Held |
| 3 | JPMORGAN CHASE & COCUSIP 46634E114 | 0.03 | 9.76% | 0.63 - | $50.48 | - | $20.81 | 0.00 | 2.75 | +$0.02B+142.59% | Held |
| 4 | WELLS FARGO & CO NEWCUSIP 949746119 | 0.02 | 6.87% | 1.00 - | $22.28 | - | $13.67 | 0.00 | 4.25 | +$0.01B+63.01% | Held |
| 5 | RESOLUTE FST PRODS INCCUSIP 76117W109 | 0.02 | 6.77% | 4.96 - | $4.42 | - | $12.15 | 0.00 | 4.25 | -$0.04B-63.66% | Held |
| 6 | Citigroup Inc.C | 0.02 | 6.43% | 0.31 -24.39% | $67.13 | $97.52 +45.27% | $47.97 | -0.10 | 4.25 | +$0.02B+103.29% | Reduced |
| 7 | SanofiSNY | 0.02 | 6.09% | 0.41 - | $48.09 | $49.22 +2.35% | $51.51 | 0.00 | 4.25 | -$0.00B-4.45% | Held |
| 8 | Teva Pharmaceutical Industries LimitedTEVA | 0.02 | 5.20% | 0.51 +134.88% | $33.34 | $20.11 -39.69% | $32.81 | +0.29 | 0.50 | -$0.01B-38.71% | Increased |
| 9 | The Goldman Sachs Group, Inc.GS | 0.02 | 5.16% | 0.07 - | $222.73 | $751.53 +237.41% | $151.25 | 0.00 | 4.25 | +$0.05B+396.87% | Held |
| 10 | ENDO INTL PLCCUSIP G30401106 | 0.01 | 3.29% | 0.95 - | $11.21 | - | $11.16 | 0.00 | 0.50 | +$0.00B+0.46% | Held |
| 11 | MBIA INC COMMBI | 0.01 | 3.16% | 1.08 - | $9.47 | - | $13.31 | 0.00 | 4.25 | -$0.00B-28.88% | Held |
| 12 | SEARS HLDGS CORPCUSIP 812350106 | 0.01 | 3.11% | 1.13 - | $8.89 | - | $26.53 | 0.00 | 4.25 | -$0.02B-66.47% | Held |
| 13 | OVERSTOCK COM INC DELCUSIP 690370101 | 0.01 | 2.94% | 0.58 - | $16.36 | - | $28.20 | 0.00 | 4.25 | -$0.01B-41.98% | Held |
| 14 | NOKIA OYJ COMMON STOCKNOK | 0.01 | 2.39% | 1.25 -54.55% | $6.18 | - | $3.74 | -1.50 | 4.25 | +$0.00B+65.33% | Reduced |
| 15 | BANK AMER CORPCUSIP 060505146 | 0.01 | 2.00% | 0.54 - | $12.09 | - | $5.46 | 0.00 | 4.25 | +$0.00B+121.36% | Held |
| 16 | BLACKBERRY LTD COMBB | 0.01 | 1.64% | 0.53 - | $10.03 | - | $7.89 | 0.00 | 4.00 | +$0.00B+27.09% | Held |
| 17 | ASCENT CAP GROUP INCCUSIP 043632108 | 0.00 | 1.46% | 0.31 - | $15.42 | - | $15.39 | 0.00 | 1.25 | +$0.00B+0.18% | Held |
| 18 | SEARS HOMETOWN & OUTLET STORCUSIP 812362101 | 0.00 | 1.11% | 1.32 - | $2.71 | - | $11.59 | 0.00 | 3.00 | -$0.01B-76.62% | Held |
| 19 | COMPUCREDIT HLDGS CORPCUSIP 20478NAD2 | 0.00 | 0.89% | 5.80 - | $0.49 | - | $0.44 | 0.00 | 1.25 | +$0.00B+12.34% | Held |
| 20 | SANDRIDGE ENERGY INCSD | 0.00 | 0.84% | 0.16 - | $17.28 | - | $20.05 | 0.00 | 0.75 | -$0.00B-13.82% | Held |
| 21 | ASCENT CAPITAL GROUP INC CV SR UNSEC NTCUSIP 043632AA6可转换债券 | 0.00 | 0.67% | 2.68 - | $0.81 | - | $1.01 | 0.00 | 3.00 | -$0.00B-20.67% | Held |
| 22 | RYANAIR HOLDINGS PLC SPONSORED ADSRYAAY | 0.00 | 0.55% | 0.02 - | $107.99 | - | $86.46 | 0.00 | 1.75 | +$0.00B+24.91% | Held |
| 23 | China Yuchai International LimitedCYD | 0.00 | 0.41% | 0.07 - | $18.28 | $34.95 +91.21% | $5.87 | 0.00 | 4.25 | +$0.00B+495.02% | Held |
| 24 | CHICAGO BRIDGE & IRON CO N V N Y REGISTRY SHCBI | 0.00 | 0.41% | 0.07 - | $19.81 | - | $34.64 | 0.00 | 1.25 | -$0.00B-42.81% | Held |
| 25 | POSCO HOLDINGS INC -SPON ADRPKX | 0.00 | 0.41% | 0.02 - | $62.81 | - | $35.05 | 0.00 | 2.00 | +$0.00B+79.21% | Held |
Showing 1-25 of 27
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.